| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |